Details for New Drug Application (NDA): 065068
✉ Email this page to a colleague
NDA 065068 describes PENICILLIN G SODIUM, which is a drug marketed by Bristol Myers Squibb, Copanos, Pharmacia And Upjohn, Sandoz, and Watson Labs Inc, and is included in five NDAs. It is available from one supplier. Additional details are available on the PENICILLIN G SODIUM profile page.
The generic ingredient in PENICILLIN G SODIUM is penicillin g sodium. There are ninety-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the penicillin g sodium profile page.
The generic ingredient in PENICILLIN G SODIUM is penicillin g sodium. There are ninety-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the penicillin g sodium profile page.
Summary for 065068
| Tradename: | PENICILLIN G SODIUM |
| Applicant: | Sandoz |
| Ingredient: | penicillin g sodium |
| Patents: | 0 |
Suppliers and Packaging for NDA: 065068
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| PENICILLIN G SODIUM | penicillin g sodium | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | 065068 | ANDA | Sandoz Inc | 0781-6153 | 0781-6153-95 | 10 VIAL in 1 CARTON (0781-6153-95) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0781-6153-94) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | Strength | 5,000,000 UNITS/VIAL | ||||
| Approval Date: | Feb 26, 2001 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
